Assyro AI

FDA Orange Book · active-ingredient family

Glucagon hydrochloride

Glucagon hydrochloride is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:GLUCAGON · NDA 201849

3

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable, powder

ProductApplicantApplicationTEApproved
GLUCAGONRLD×2FRESENIUS KABI USANDA 201849May 08, 2015
GLUCAGENRLD×2NOVO NORDISKNDA 020918Jun 22, 1998
GLUCAGONRLD×2LILLYNDA 012122Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Glucagon hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.